Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/AVECHO-BIOTECHNOLOGY-LIMI-59029824/news/Avecho-Biotechnology-Limited-erhalt-Ethik-Genehmigung-fur-seine-klinische-Phase-III-Studie-zur-Erp-42615589/?utm_source=whatsapp&utm_medium=social&utm_campaign=share